Chemotherapy method uses patient's own cells as trojan horse to direct cancer-killing drugs to tumours
MedicalXpress Breaking News-and-Events | Feb 27, 2024
Study reveals new insights into immune system role in lung cancer risk
MedicalXpress Breaking News-and-Events | Feb 24, 2024
'Virtual biopsy' uses AI to help doctors assess lung cancer
MedicalXpress Breaking News-and-Events | Feb 23, 2024
Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients
MedicalXpress Breaking News-and-Events | Feb 15, 2024
One protein is key to the spread of lung cancer: New study finds a way to stop it
MedicalXpress Breaking News-and-Events | Nov 29, 2023
Immunotherapy drug is well tolerated in lung cancer patients with limited physical function, study suggests
MedicalXpress Breaking News-and-Events | Nov 23, 2023
Pathologic scoring shows promise for assessing lung tumour therapy response
MedicalXpress Breaking News-and-Events | Nov 11, 2023
International study shows lung cancer screening dramatically increases long-term survival rate
MedicalXpress Breaking News-and-Events | Nov 09, 2023
Lung cancer researchers identify specific genetic change that predicts whether patients can respond to targeted therapy
MedicalXpress Breaking News-and-Events | Nov 09, 2023
Research finds non-small cell lung cancer drug lorlatinib targets additional protein
MedicalXpress Breaking News-and-Events | Oct 18, 2023